Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials

Written By Fanny Elahi

Staffaroni AM, Ljubenkov PA, Kornak J, Cobigo Y, Datta S, Marx G, Walters SM, Chiang K, Olney N, Elahi FM, Knopman DS, Dickerson BC, Boeve BF, Gorno-Tempini ML, Spina S, Grinberg LT, Seeley WW, Miller BL, Kramer JH, Boxer AL, Rosen HJ (2019) Brain

Fanny Elahi
Previous

Increases in a pro-inflammatory chemokine, MCP-1, are related to decreases in memory over time
Next

Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease